Status Quo of Decision-making Readiness in Lung Cancer Chemotherapy Patients and Its Influencing Factors
Objective To explore the status quo of decision-making readiness in lung cancer chemotherapy patients and its influencing factors,and to provide reference for clinical implementation of auxiliary decision-making interventions.Methods From January to December 2022,366 patients with lung cancer chemotherapy admitted to the Respiratory Department and Thoracic Surgery Department of a tertiary A hospital in Zhengzhou City were selected by the convenience sampling method.The questionnaire survey was conducted using the Preparation for Decision Making Scale,Treatment Decision-making Attitude Scare,Perceived Social Support Scale,and Decisional Conflict Scale.Results A total of 366 patients with lung cancer chemotherapy were included.The scores of decision readiness,treatment decision attitude,decision dilemma and social support were(63.68±5.56),(23.00±4.20),(34.21±7.67)and(60.92±5.46),respectively.There were significant differences in decision readiness scores among patients with different age,education,stage and treatment mode(all P＜0.0l).Decision readiness was positively correlated with treatment decision attitude(r=0.800)and negatively correlated with decision dilemma(r=-0.405).It was positively correlated with social support(r=0.528).Age,education level,disease stage,treatment style,treatment decision attitude,decision dilemma state and social support were the influencing factors of decision readiness(all P＜0.05),accounting for 68.5％of the total variation.Conclusion The decision readiness of lung cancer patients undergoing chemotherapy was at a medium level.Medical staff should focus on patients with advanced age,low education level,various treatment methods and late disease stages to help them establish a positive decision-making attitude and improve their decision-making dilemma.
lung cancer chemotherapy patientdecision readinessdecision-making attitudedecision-making dilemmasocial supportinfluencing factor
万方数据
维普
